Boglione L, Crobu M, Pirisi M, Smirne C
Viruses. 2025; 17(1).
PMID: 39861829
PMC: 11769566.
DOI: 10.3390/v17010040.
Huang S, Long H, Huang J
Pathogens. 2025; 14(1).
PMID: 39860969
PMC: 11768139.
DOI: 10.3390/pathogens14010008.
De D, Mehta H, Shah S, Ajithkumar K, Barua S, Chandrashekar L
Indian Dermatol Online J. 2025; 16(1):3-24.
PMID: 39850690
PMC: 11753534.
DOI: 10.4103/idoj.idoj_1059_24.
Park J, Kim D, Gee H, Yu H, Yang J, Hwang S
Int J Mol Sci. 2025; 26(1.
PMID: 39796114
PMC: 11719695.
DOI: 10.3390/ijms26010259.
Louhab I, Daoudi H, Elcadi M, El Amin G, Zouaki A, Zirar J
Cureus. 2024; 16(11):e73550.
PMID: 39677079
PMC: 11638146.
DOI: 10.7759/cureus.73550.
Rituximab use in Rheumatoid Arthritis: A Seven-Year Retrospective Study of 52 Patients at a Saudi Arabian Hospital.
Bafana S, Alenzi F, Almaghlouth I, Alqurtas E, Bedaiwi M, Almalag H
Med Sci Monit. 2024; 30:e946178.
PMID: 39616437
PMC: 11619177.
DOI: 10.12659/MSM.946178.
Renal Manifestations of Chronic Hepatitis C: A Review.
Sohal A, Singh C, Bhalla A, Kalsi H, Roytman M
J Clin Med. 2024; 13(18).
PMID: 39337023
PMC: 11433393.
DOI: 10.3390/jcm13185536.
Management of infections for patient treated with ibrutinib in clinical practice.
Barate C, Scortechini I, Ciofini S, Picardi P, Angeletti I, Loscocco F
Front Oncol. 2024; 14:1428464.
PMID: 39319061
PMC: 11420164.
DOI: 10.3389/fonc.2024.1428464.
Infectious Disease Prophylaxis During and After Immunosuppressive Therapy.
Schweitzer L, Miko B, Pereira M
Kidney Int Rep. 2024; 9(8):2337-2352.
PMID: 39156157
PMC: 11328545.
DOI: 10.1016/j.ekir.2024.04.043.
Hepatitis B virus infection, infertility, and assisted reproduction.
Zhang L, Zhang F, Ma Z, Jin J
J Zhejiang Univ Sci B. 2024; 25(8):672-685.
PMID: 39155780
PMC: 11337088.
DOI: 10.1631/jzus.B2300261.
The Epidemiology, Transmission, Genotypes, Replication, Serologic and Nucleic Acid Testing, Immunotolerance, and Reactivation of Hepatitis B Virus.
Patel A, Dossaji Z, Gupta K, Roma K, Chandler T, Minacapelli C
Gastro Hep Adv. 2024; 3(2):139-150.
PMID: 39129942
PMC: 11307719.
DOI: 10.1016/j.gastha.2023.10.008.
Could Hepatitis B Reactivation be Overlooked in Patients with Resolved Hepatitis B Virus Infection and Receiving Immunosuppressive Treatment?.
Acar S, Eminler A
Turk J Gastroenterol. 2024; 35(4):350-351.
PMID: 39128114
PMC: 11114244.
DOI: 10.5152/tjg.2024.23534.
Impact of universal hepatitis B virus (HBV) screening using chemotherapy orders on the HBV reactivation in cancer patients.
Marty C, Adam J, Martel-Laferriere V, Doucet S, Martel D
Support Care Cancer. 2024; 32(8):541.
PMID: 39046551
DOI: 10.1007/s00520-024-08750-6.
Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors.
Savaliya B, Shekouhi R, Mubarak F, Manaise H, Jimenez P, Kowkabany G
World J Gastroenterol. 2024; 30(24):3052-3058.
PMID: 38983963
PMC: 11230056.
DOI: 10.3748/wjg.v30.i24.3052.
Management of HBV reactivation: Challenges and opportunities.
Mezzacappa C, Lim J
Clin Liver Dis (Hoboken). 2024; 23(1):e0143.
PMID: 38720793
PMC: 11078521.
DOI: 10.1097/CLD.0000000000000143.
Hepatitis B virus reactivation in patients treated with monoclonal antibodies.
De Pauli S, Grando M, Miotti G, Zeppieri M
World J Virol. 2024; 13(1):88487.
PMID: 38616853
PMC: 11008406.
DOI: 10.5501/wjv.v13.i1.88487.
Risk of Hepatitis B Reactivation in Patients Receiving Ibrutinib: The National Veterans Affairs Cohort.
Chen T, Jacob D, Coppin J, Jinadatha C
Open Forum Infect Dis. 2024; 11(3):ofae008.
PMID: 38434611
PMC: 10904287.
DOI: 10.1093/ofid/ofae008.
Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy.
Cohen E, Regev A, Garg A, Di Bisceglie A, Lewis J, Vierling J
Drug Saf. 2024; 47(4):321-332.
PMID: 38353882
PMC: 10954982.
DOI: 10.1007/s40264-024-01399-4.
Change in Hepatitis B Surface Antibody Titers After Chemotherapy in Patients With Hematological Malignancies.
Ulusoy T, Tiglioglu P, Demirkose H, Albayrak M, Sencan I
Cureus. 2024; 16(1):e51572.
PMID: 38314000
PMC: 10836041.
DOI: 10.7759/cureus.51572.
The Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Receiving Tocilizumab: A Systematic Review and Meta-Analysis.
Ko P, Kuo M, Kao I, Wu C, Tseng C, Shao S
Viruses. 2024; 16(1).
PMID: 38257778
PMC: 10820547.
DOI: 10.3390/v16010078.
